Chevron Corporation
NYSE · USD
Mega cap
1.98× peer median
1.55× peer median
51% less volatile
Claude reads this page's data and writes up Chevron Corporation's financials, valuation and analyst coverage: built only from the figures here, with nothing pulled in from elsewhere.
Generated by an AI model from the data on this page. It can be wrong, and it isn't investment advice or a recommendation to buy or sell anything. Check every figure against the sections themselves before you rely on it.
$155.6B in FY21 to $184.4B in FY25, with the latest year down 4.6%, slower than the trend.
Growth · FY25
$35.5B of net debt against $33.9B of annual operating cash flow.
Liquidity · FY25
$38.6B of current assets against $33.4B due within a year.
Liquidity · FY25
10.3% in FY21 to 9.0% in FY25.
Profitability · FY25
Free cash flow of $16.6B covers the business without outside capital, on $6.5B of cash and short-term investments.
Liquidity · FY25
$184.4B of revenue against $167.8B of operating costs, leaving $16.6B.
Profitability · FY25
$110.1B of free cash flow against $102.4B of net income across 5 fiscal years.
Quality · FY25
Revenue came in above consensus by 1.0% on average over the last four reports.
Quality · Jul '26
Chevron (CVX), the integrated energy heavyweight, secured a fresh route into Ghana's deepwater oil patch while its shares traded at $212.70 on Sept. 3. Reuters
September's rate and oil pressures could drive sector rotation, favoring energy, financials and defensive healthcare over growth stocks.
Although Chevron (NYSE:CVX | CVX Price Prediction) shares have climbed to a 52-week high on the back of a $7 billion Venezuela expansion, to above $214 per share, Wall Street's memory tends to be shorter than the deals it finances.
Washington just handed a 100-year lease on tens of billions of barrels of Venezuelan oil to a private company nobody has heard of, while Chevron quietly hit a 52-week high on a completely separate deal. The two stories are getting conflated in ways that could cost investors.
Not all Dividend Aristocrats are created equal, and three companies spanning payroll processing, supplemental insurance, and integrated energy have quietly stacked 25-plus years of annual raises through completely different cash engines.
Chevron just placed a multi-billion dollar bet on Venezuelan oil within days of a historic U.S.
Average month-end to month-end move for CVXin each calendar month. Point at a bar for that month's spread: past seasonality is a tendency in a small sample, not a forecast.
−$9.0B vs FY24
FY24 → FY25
FY21 → FY25, annualized
+11.2% vs the four before
Q2 FY26 · +51.4% YoY
Share of the latest fiscal year, largest first. The line is the segment across every fiscal year we have: hover it to read one. “Not broken out” is the remainder, pinned last whatever its size: the named segments reach 64% of reported revenue, and the rest was filed without a segment label at all.
No filing with a machine-readable geographic breakdown for CVX yet.
−4.6% YoY
+1.0 pp YoY
−6.0 pp YoY
−30.4% YoY
−2.5 pp YoY
−31.9% YoY
+10.3% YoY
−$18.3B YoY
| $ billions | FY25 | FY24 | FY23 | FY22 | FY21 |
|---|---|---|---|---|---|
| Cash & equivalents | 6.5 | 6.8 | 8.2 | 17.7 | 5.6 |
| Short-term investments | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 |
| Receivables | 18.1 | 20.7 | 19.9 | 20.5 | 18.4 |
| $ billions | FY25 | FY24 | FY23 | FY22 | FY21 |
|---|---|---|---|---|---|
| Operating cash flow | 33.9 | 31.5 | 35.6 | 49.6 | 29.2 |
| Capital expenditure | −17.3 | −16.4 | −15.8 | −12.0 | −8.1 |
| Free cash flow | 16.6 | 15.0 | 19.8 |
P/E vs EPS growth · below the channel = cheaper for its growth
P/S vs revenue growth · below the channel = cheaper for its growth
| Ticker | P/E | Fwd P/E | PEG | P/S | Fwd P/S | PSG | EPS gr | Rev gr |
|---|---|---|---|---|---|---|---|---|
| CVX | 20.2 | 13.3 | 0.55 | 2.0 | 1.8 | 0.35 | 24% | 5% |
| XOM | 20.9 | 14.0 | 0.90 | 1.9 | 1.7 | 0.26 | 16% | 7% |
| SHEL | 10.2 | 8.3 | 0.55 | 0.9 | 0.8 | 0.18 | 15% | 4% |
| TTE | 11.1 | 8.3 | 0.50 | 1.0 | 1.0 | 0.91 | 17% | 1% |
| PBR | 4.7 | 4.7 | 1.02 | 1.3 | 1.2 | 0.18 | 5% | 7% |
| PBR-A | 4.7 | 4.2 | 0.75 | 1.3 | 1.1 | 0.16 | 6% | 7% |
Dots = reported EPS vs consensus · gap = surprise · dashed = estimate ($)
Solid = reported · dashed = forward consensus · shaded = analyst low–high ($B)
Rows: discount rate (r) · Columns: terminal growth (g∞) · cell = fair value, shaded by up/downside vs 211.
Last 12M · $139M bought · $572M sold · net −$433M
| Inventory |
|---|
| 9.7 |
| 9.1 |
| 8.6 |
| 8.2 |
| 6.8 |
| Total current assets | 38.6 | 40.9 | 41.1 | 50.3 | 33.7 |
|---|
| Property, plant & equipment | 225.8 | 147.8 | 153.6 | 143.6 | 147.0 |
|---|
| Long-term investments | 45.7 | 47.4 | 46.8 | 45.2 | 40.7 |
|---|
| Other non-current assets | 14.0 | 20.8 | 20.1 | 18.5 | 18.1 |
|---|
| Total assets | 324.0 | 256.9 | 261.6 | 257.7 | 239.5 |
|---|
| Accounts payable | 19.2 | 22.1 | 20.4 | 19.0 | 16.5 |
|---|
| Short-term debt | 2.8 | 4.3 | 0.5 | 1.9 | 0.2 |
|---|
| Total current liabilities | 33.4 | 38.6 | 32.3 | 34.2 | 26.8 |
|---|
| Long-term debt | 39.1 | 19.6 | 19.7 | 21.0 | 30.7 |
|---|
| Total liabilities | 131.8 | 103.8 | 99.7 | 97.5 | 99.6 |
|---|
| Shareholders’ equity | 186.4 | 152.3 | 161.0 | 159.3 | 139.1 |
|---|
Fiscal year · latest five reported years
| 37.6 |
| 21.1 |
| Investing cash flow | −15.9 | −8.9 | −15.2 | −12.1 | −5.9 |
|---|
| Dividends paid | −12.8 | −11.8 | −11.3 | −11.0 | −10.2 |
|---|
| Share buybacks | −12.1 | −15.4 | −14.9 | −11.3 | −1.4 |
|---|
| Net debt issued / (repaid) | 5.9 | 3.6 | −4.1 | −8.5 | −12.9 |
|---|
| Financing cash flow | −19.1 | −23.5 | −30.1 | −25.0 | −23.1 |
|---|
| Net change in cash | −1.0 | −1.0 | −9.8 | 12.3 | 0.1 |
|---|
Fiscal year · outflows shown negative